Stockscreener 앱 받기
47.78
0.23%
0.11
전일 마감가:
$47.67
열려 있는:
$47.55
하루 거래량:
1.79M
Relative Volume:
1.04
시가총액:
$6.25B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-10.39
EPS:
-4.6
순현금흐름:
$-616.24M
1주 성능:
-1.87%
1개월 성능:
+12.82%
6개월 성능:
+40.65%
1년 성능:
-45.94%
1일 변동 폭
$47.50
$49.41
1주일 범위
$47.02
$50.18
52주 변동 폭
$27.66
$94.76
백스사이트 Stock (PCVX) Company Profile
명칭
Vaxcyte Inc
전화
650-837-0111
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
47.78 | 6.24B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
백스사이트 Stock (PCVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-12 | 개시 | Goldman | Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 개시 | Goldman | Buy |
| 2023-12-07 | 개시 | Mizuho | Buy |
| 2023-04-18 | 개시 | TD Cowen | Outperform |
| 2023-01-03 | 재확인 | Needham | Buy |
| 2022-12-15 | 개시 | Guggenheim | Buy |
| 2022-11-17 | 개시 | BTIG Research | Buy |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-06-24 | 재개 | Jefferies | Buy |
| 2020-07-07 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 개시 | Needham | Buy |
모두보기
백스사이트 주식(PCVX)의 최신 뉴스
Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound - Yahoo Finance
Mizuho Securities Sticks to Their Buy Rating for Vaxcyte (PCVX) - The Globe and Mail
How Vaxcyte Inc. stock reacts to Fed rate cutsWeekly Trade Report & Free Technical Pattern Based Buy Signals - newser.com
Is Vaxcyte Inc. stock vulnerable to regulatory risksEarnings Growth Report & Risk Managed Investment Entry Signals - newser.com
Will Vaxcyte Inc. stock continue upward momentumQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com
Is Vaxcyte Inc. (5VA) stock a top hedge fund pickJuly 2025 Action & Momentum Based Trading Ideas - newser.com
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners By Investing.com - Investing.com South Africa
PCVX: 31-Valent vaccine nears phase III, targeting major market growth and expanded global demand - TradingView
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners - Investing.com Canada
What analyst consensus says on Vaxcyte Inc. stockTrade Entry Report & High Conviction Trade Alerts - newser.com
(PCVX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Can momentum traders help lift Vaxcyte Inc.July 2025 Action & Precise Swing Trade Entry Alerts - newser.com
Is Vaxcyte Inc. stock poised for growthEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Will Vaxcyte Inc. benefit from macro trendsPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Vaxcyte Inc Stock Analysis and ForecastStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Vaxcyte stock up on results from mid-stage trial of its pneumococcal vaccine - MSN
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vaxcyte (BIT:1PCVX) Price Target Decreased by 15.42% to 72.37 - Nasdaq
Is Vaxcyte’s (PCVX) Aggressive R&D Spend Still Justified Amid Widening Losses? - simplywall.st
Should you wait for a breakout in Vaxcyte Inc.July 2025 Review & High Conviction Investment Ideas - newser.com
Quantitative breakdown of Vaxcyte Inc. recent move2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Has Vaxcyte Inc. found a price floorBond Market & Smart Investment Allocation Insights - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgrades2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Using data tools to time your Vaxcyte Inc. exitChart Signals & Daily Market Momentum Tracking - newser.com
Will Vaxcyte Inc. stock benefit from commodity prices2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Vaxcyte’s Stock Juggle: Opportunity or Risk? - StocksToTrade
What moving averages say about Vaxcyte Inc.Market Rally & Reliable Breakout Forecasts - newser.com
When is the best time to exit Vaxcyte Inc.Market Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
백스사이트 (PCVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):